Enrique M. Ocio, MD, PhD, Marqués de Valdecilla University Hospital, Santander, Spain, shares what he’s looking forward to at the virtual European Hematology Association (EHA) Congress 2021, in particular highlighting updates on new combinations in the frontline setting for multiple myeloma, and novel data on bispecific antibodies, antibody-drug conjugates and chimeric antigen receptor T-cell (CAR-T) therapy.